02/08/2010-Shares of CVS Caremark (NYSE:CVS) are trading 2.7% higher to $31.91 premarket Monday after the company reported Q4 EPS of $0.79, ex-items, topping consensus estimates of $0.78.

Revenues for the quarter rose 7% year-over-year to $25.8 billion, missing consensus estimates of $26.2 billion.

Sales at stores open at least a year grew 4.9%.

Tom Ryan, Chairman, President, and Chief Executive Officer, commented, "We made good progress in 2009 in solidifying our position as the largest pharmacy health care provider in the nation with the broadest capabilities. We continued to make investments and forge strategic alliances that will enable us to capitalize on the evolving health care landscape and further differentiate our offerings in the marketplace. At the same time, we delivered financial performance ahead of our initial plan for the year, including the solid quarter we announced today. I'm very pleased to report continued industry-leading performance in our retail pharmacy business and solid performance in our PBM, which resulted in double-digit EPS growth and significant free cash flow generation."

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html